Last quarter (Q ), Medical Care Technologies's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q, Medical Care Technologies's net income was $-709.81K. See Medical Care Technologies’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 11	Dec 10	Dec 09	Dec 08	Dec 07
Total Revenue	-	$ 0.00	$ 0.00	$ 0.00	$ 0.00	-
Cost of Revenue	-	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	-	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Operating Expense	$ 1.22M	$ 1.21M	$ 2.19M	$ 84.36K	$ 5.97K	$ 37.54K
Operating Income	$ -1.22M	$ -1.21M	$ -2.19M	$ -84.36K	$ -5.97K	$ -37.54K
Net Non Operating Interest Income Expense	$ -531.08K	$ -487.17K	$ -341.00	-	-	-
Other Income Expense	$ -1.14M	$ -229.61K	$ 2.12K	$ -764.00	-	-
Pretax Income	$ -2.05M	-	-	-	-	-
Tax Provision	-	-	-	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -2.88M	$ -1.92M	$ -2.19M	$ -85.12K	$ -55.74K	$ -37.54K
Basic EPS	-	-	-	-	-	$ -20.00K
Diluted EPS	-	-	-	-	-	$ -20.00K
Basic Average Shares	$ 2.61K	$ 154.00	$ 80.00	$ 49.00	$ 49.00	-
Diluted Average Shares	$ 2.61K	$ 154.00	$ 80.00	$ 49.00	$ 49.00	-
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 1.22M	$ 1.21M	$ 2.19M	$ 84.36K	$ 5.97K	$ 37.54K
Interest Expense	$ 531.08K	$ 487.17K	$ 341.00	-	-	-
Net Income From Continuing And Discontinued Operation	$ -2.88M	$ -1.92M	$ -2.19M	$ -85.12K	$ -55.74K	$ -37.54K
Normalized Income	$ -1.74M	$ -1.69M	$ -2.19M	$ -84.36K	$ -5.97K	$ 0.00
EBIT	$ -1.96M	$ -1.21M	$ -2.19M	$ -84.36K	$ -5.97K	$ -37.54K
EBITDA	$ -1.97M	$ -1.20M	$ -1.70M	$ -84.36K	$ -5.97K	$ -37.54K

Currency in USD

Medical Care Technologies Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing